Sign Up Today and Learn More About Neuralink Stock
Invest in or calculate the value of your shares in Neuralink or other pre-IPO companies through EquityZen's platform.
About Neuralink Stock
Founded
2017
Total Funding
688M
Industries
Hardware, Software, Science and Engineering
Neuralink is a neurotechnology company that develops brain-computer interfaces (BCIs) to enable direct communication between the human brain and computers. The company's technology aims to help individuals with neurological disorders regain mobility and communication abilities while also exploring future applications for human-AI integration. By advancing implantable brain devices, Neuralink seeks to push the boundaries of neuroscience and human enhancement.
Neuralink was founded in 2016 and is headquartered in Fremont, CA. Notable investors include Elon Musk.
Neuralink Press Mentions
Stay in the know about the latest news on Neuralink
Elon Musk’s robot baby Jesus
dailydot • Mar 02, 2025
Elon Musk, Shivon Zilis welcome 4th child: A look at their relationship history, a ‘blended family deal’ with Grimes
livemint • Mar 01, 2025
Elon Musk is a dad again! Tesla CEO welcomes 14th child with partner Shivon Zilis
economictimes • Mar 01, 2025
Elon Musk's girlfriend Shivon Zilis announces their 4th kid: Discussed with Elon and …
timesofindia • Mar 01, 2025
Elon Musk’s family tree explained as Tesla CEO becomes father for 14th time, welcomes 4th child with Shivon Zilis
livemint • Mar 01, 2025
Investors in Neuralink
Discover investors in Neuralink stock and explore their portfolio companies
Neuralink Management
Leadership team at Neuralink
Founder
Elon Musk
Join now and verify your accreditation status to gain access to:
- Neuralink Current Valuation
- Neuralink Stock Price
- Neuralink Management
- Available deals in Neuralink and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Neuralink Cap Table and Funding History by Share Class and Liquidity Preferences
- Neuralink Revenue and Financials
- Neuralink Highlights
- Neuralink Business Model
- Neuralink Risk Factors
- Neuralink Research Report from SACRA Research
Trading Neuralink Stock
How to invest in Neuralink stock?
Accredited investors can buy pre-IPO stock in companies like Neuralink through EquityZen funds. These investments are made available by existing Neuralink shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Neuralink stock?
Shareholders can sell their Neuralink stock through EquityZen's private company marketplace. EquityZen's network includes over 350K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 45K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
